Quantcast

Latest Alere Inc. Stories

2014-07-01 08:29:16

Ron Zwanziger Resigns as Chief Executive Officer and President; Namal Nawana Appointed Interim CEO WALTHAM, Mass., July 1, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, today announced as part of its ongoing review of its strategy and operations, that Chief Operating Officer Namal Nawana has been...

2014-06-23 12:29:10

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Enteric Disease Testing Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_enteric_disease_testing_market_2014_2018.html TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric...

2014-06-18 12:35:49

WALTHAM, Mass., June 18, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced that it has elected not to proceed at this time with its previously announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI Diagnostics Group plc, or BBI Diagnostics, and intends to seek greater value for the businesses of BBI Diagnostics than could be realized under current equity market conditions in the United Kingdom. Alere remains committed to its...

2014-06-16 08:29:05

First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Alere(TM) i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less...

2014-06-05 16:27:12

WALTHAM, Mass., June 5, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced that it has received the requisite consents for its consent solicitations commenced on May 21, 2014 relating to certain waivers and amendments under the respective indentures (together, the "Notes Modifications") governing its 7.25% Senior Notes due 2018 (the "7.25% Notes"), its 8.625% Senior Subordinated Notes due 2018 (the "8.625% Notes") and its 6.5% Senior Subordinated Notes due 2020 (the...

2014-05-22 16:27:20

WALTHAM, Mass., May 22, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, announced today that it will attend three separate healthcare conferences in June. Jon Russell, Vice President, Finance, will attend and present at all three events. Conference information and presentation schedule are as follows: Jefferies...

2014-05-21 20:21:38

WALTHAM, Mass., May 21, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today that it has commenced a consent solicitation relating to its 7.250% Senior Notes due 2018 (the "7.250% Notes"), its 8.625% Senior Subordinated Notes due 2018 (the "8.625% Notes") and its 6.500% Senior Subordinated Notes due 2020 (the "6.500% Notes," and, together with the 7.250% Notes and the 8.625% Notes, the "Notes"). The Company is soliciting the consents of the requisite holders of...

2014-05-15 20:23:40

WALTHAM, Mass., May 15, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on July 15, 2014 to holders of record of Series B stock at the close of business on July 1,...

2014-05-06 08:35:23

Healthcare Professionals Should Stop Using Strips WALTHAM, Mass., May 6, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) has initiated a voluntary Class 1 recall in the U.S. of the Alere INRatio2 PT/INR Professional Test Strips (PN 99008G2). This action is a result of complaints of patients who had a therapeutic or near therapeutic INR with the Alere INRatio2 PT/INR Professional Test Strip but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory. Alere...

2014-05-05 08:29:05

WALTHAM, Mass., May 5, 2014 /PRNewswire/ -- As part of its ongoing review and enhancement of its corporate governance policies, Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, announces today that it has separated the roles of Chairman of the Board and Chief Executive Officer. The Board of Directors unanimously elected Gregg J....


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.